Furthermore, siRNA against HOXC6 significantly reduces the growth of xenograft tumors in mice with oral cancer [31] and upregulation of miR-495 can inhibit the growth of OSCC xenografts in vivo [28], which were in agreement with our in vivo experimental results. Here, HOXC6 is linked to lip and oral cavity carcinoma.